| Date Filed | Type | Description |
| 04/27/2021 |
GN
| STERIS to Host a Conference Call for Fiscal 2021 Fourth Quarter and Full Year Financial Results on May 19, 2021 |
| 03/26/2021 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/24/2021 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 03/23/2021 |
S-3ASR
| Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers: |
| 02/03/2021 |
GN
| STERIS Announces Leadership Succession Plan |
| 02/02/2021 |
GN
| STERIS Announces Financial Results for Fiscal 2021 Third Quarter |
| 01/19/2021 |
GN
| STERIS to Host a Conference Call for Fiscal 2021 Third Quarter Financial Results on February 3, 2021 |
| 01/12/2021 |
GN
| STERIS Announces Definitive Agreement to Acquire Cantel Medical |
| 01/07/2021 |
GN
| STERIS To Participate in Upcoming Investor Conferences |
| 11/18/2020 |
GN
| STERIS Completes Acquisition of Key Surgical |
| 11/02/2020 |
GN
| STERIS Announces Financial Results for Fiscal 2021 Second Quarter |
| 10/20/2020 |
GN
| STERIS to Host a Conference Call for Fiscal 2021 Second Quarter Financial Results on November 3, 2020 |
| 10/06/2020 |
GN
| STERIS Expands Healthcare Consumables Offering with Acquisition of Key Surgical for approximately $850 million |
| 08/03/2020 |
GN
| STERIS Announces Financial Results for Fiscal 2021 First Quarter |
| 07/22/2020 |
GN
| STERIS to Host a Conference Call for Fiscal 2021 First Quarter Financial Results on August 4, 2020 |
| 05/26/2020 |
GN
| STERIS Announces Second On-site Decontamination Solution for Respiratory Masks |
| 05/13/2020 |
GN
| STERIS Announces Financial Results for Fiscal 2020 Fourth Quarter and Full Year |
| 04/10/2020 |
GN
| STERIS Announces Decontamination Solution for Respiratory Masks |
| 02/19/2020 |
GN
| STERIS to Participate in the Raymond James Institutional Investor Conference |
| 01/27/2020 |
GN
| STERIS to Host a Conference Call for Fiscal 2020 Third Quarter Financial Results on February 11, 2020 |
| 11/04/2019 |
GN
| STERIS Announces Financial Results for Fiscal 2020 Second Quarter |
| 08/26/2019 |
GN
| STERIS to Participate in the Morgan Stanley Global Healthcare Conference |
| 08/05/2019 |
GN
| STERIS Announces Financial Results for Fiscal 2020 First Quarter |
| 05/13/2019 |
GN
| STERIS Announces Financial Results for Fiscal 2019 Fourth Quarter and Full Year |
| 04/30/2019 |
GN
| STERIS to Host a Conference Call for Fiscal 2019 Fourth Quarter and Full Year Financial Results on May 14, 2019 |
| 01/22/2019 |
GN
| Report: Developing Opportunities within Macy's, Leggett & Platt, Tyler Technologies, BioScrip, DXC Technology, and STERIS plc — Future Expectations, Projections Moving into 2019 |
| 10/22/2018 |
GN
| Report: Developing Opportunities within Balchem, STERIS plc, Tableau Software, Werner Enterprises, Wabco, and Weis Markets — Future Expectations, Projections Moving into 2018 |
| 03/21/2018 |
GN
| New Research Coverage Highlights Monolithic Power, Alleghany, O'Reilly Automotive, Associated Banc-Corp, BancFirst, and STERIS plc — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 06/09/2017 |
GN
| UFP Technologies Elects Cynthia Feldmann to its Board |
| 02/09/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/10/2015 |
SC 13G/A
| FMR LLC reports a 0% stake in STERIS CORPORATION |
| 11/10/2015 |
SC 13G/A
| BlackRock Inc. reports a 12% stake in STERIS CORP |
| 11/06/2015 |
8-K
| Quarterly results |
| 11/02/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|